Otamixaban
Encyclopedia
Otamixaban is a direct factor Xa inhibitor
, currently being developed by the French pharmaceutical company Sanofi-Aventis
as a treatment for acute coronary syndrome
.
Direct factor Xa inhibitor
Direct factor Xa inhibitors are a class of anticoagulant drugs which act directly upon Factor X in the coagulation cascade, without using antithrombin as a mediator.-Clinical uses:Direct factor Xa inhibitors are being used clinically...
, currently being developed by the French pharmaceutical company Sanofi-Aventis
Sanofi-Aventis
Sanofi S.A. is a multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but the...
as a treatment for acute coronary syndrome
Acute coronary syndrome
Acute coronary syndrome is usually one of three diseases involving the coronary arteries: ST elevation myocardial infarction , non ST elevation myocardial infarction , or unstable angina ....
.